What Labs Should Expect — and Demand — from FDA's New LDT Strategy

DECK: As labs accustomed to CLIA and state regulations are forced to face costly and time-consuming 510(k) and PMA requirements, "it will be a very significant change." As one lab manager told me, "I just don't know how we're going to pay for it."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.